don't forget 1may, page-5

cp82,

I don't think even springtree has a 5% stake in PRR (I could be wrong).

DNDN may wish to use any spare cash towards getting their production facilities up and running as quickly as possible.

The common factor of 'springtree' between DNDN and PRR would have some bearing on the communications between DNDN and PRR management. I think that PRR management may have actually mentioned the advantage of being able to get useful information from DNDN regarding the FDA process.

I think you hit the nail on the head cp82 regarding the possibilities for PRR if the trials are successful.

PRR has risk associated with the results of the trials and the FDA approval (including ODS).

Don't get me wrong, I hold PRR and have a long term view on it. I think that patience will pay off in the end.

We just have to wait for any updates on the progress.

Good Luck to All Long Term Holders of PRR.

Cheers,

Jai.